ADCT financials
ADC Therapeutics (ADCT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- ADCT revenue was $81.36M in fiscal 2025, net income -$142.62M.
ADCT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $81.36M | $75.56M | -$121.50M | -$142.62M | -1.12 |
| 2024 | $70.84M | $64.89M | -$130.65M | -$157.85M | -1.62 |
| 2023 | $69.56M | $67.03M | -$165.99M | -$240.05M | -2.94 |
| 2022 | $209.91M | $206.61M | -$123.34M | -$157.13M | -2.01 |